Superior persistence of ustekinumab compared to anti-TNF in vedolizumab-experienced inflammatory bowel diseases patients: a real-world cohort study.
Saved in:
| Title: | Superior persistence of ustekinumab compared to anti-TNF in vedolizumab-experienced inflammatory bowel diseases patients: a real-world cohort study. |
|---|---|
| Authors: | Chiu, Horng-Yih1 (AUTHOR), Kuo, Chia-Jung2,3,4,5 (AUTHOR), Lai, Ming-Wei3,6 (AUTHOR), Wu, Ren-Chin3,7 (AUTHOR), Chen, Chien-Ming3,8 (AUTHOR), Chiu, Cheng-Tang2,3,4,5 (AUTHOR), Pan, Yu-Bin9 (AUTHOR), Chiu, Cheng-Hsun4,10 (AUTHOR), Le, Puo-Hsien2,3,4,5 (AUTHOR) puohsien@gmail.com |
| Source: | BMC Gastroenterology. 12/31/2024, Vol. 24 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
